CN103764665A - 使用分选酶安装用于蛋白质连接的点击化学柄 - Google Patents
使用分选酶安装用于蛋白质连接的点击化学柄 Download PDFInfo
- Publication number
- CN103764665A CN103764665A CN201280042272.7A CN201280042272A CN103764665A CN 103764665 A CN103764665 A CN 103764665A CN 201280042272 A CN201280042272 A CN 201280042272A CN 103764665 A CN103764665 A CN 103764665A
- Authority
- CN
- China
- Prior art keywords
- protein
- click chemistry
- antibody
- chemistry handle
- handle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*(C)C(C1C=CC=C1)=O Chemical compound C*(C)C(C1C=CC=C1)=O 0.000 description 6
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161502237P | 2011-06-28 | 2011-06-28 | |
| US61/502,237 | 2011-06-28 | ||
| US201261624114P | 2012-04-13 | 2012-04-13 | |
| US61/624,114 | 2012-04-13 | ||
| PCT/US2012/044584 WO2013003555A1 (en) | 2011-06-28 | 2012-06-28 | Using sortases to install click chemistry handles for protein ligation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103764665A true CN103764665A (zh) | 2014-04-30 |
Family
ID=47424537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280042272.7A Pending CN103764665A (zh) | 2011-06-28 | 2012-06-28 | 使用分选酶安装用于蛋白质连接的点击化学柄 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10081684B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2726494B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2014525904A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103764665A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012275390A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2840409A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013003555A1 (cg-RX-API-DMAC7.html) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104130308A (zh) * | 2014-07-29 | 2014-11-05 | 吉林大学 | 一种蛋白质定点peg修饰的方法及所得peg修饰的蛋白质 |
| CN108026560A (zh) * | 2015-09-25 | 2018-05-11 | 豪夫迈·罗氏有限公司 | 在低共熔溶剂中使用分选酶的转酰胺反应 |
| CN108271375A (zh) * | 2015-09-25 | 2018-07-10 | 豪夫迈·罗氏有限公司 | 包含分选酶缀合环的重组免疫球蛋白重链及其缀合物 |
| CN109072212A (zh) * | 2016-03-30 | 2018-12-21 | 豪夫迈·罗氏有限公司 | 改善的分选酶 |
| WO2020151762A1 (zh) * | 2019-01-25 | 2020-07-30 | 信达生物制药(苏州)有限公司 | 新型双特异性抗体分子以及同时结合pd-l1和lag-3的双特异性抗体 |
| WO2020181756A1 (zh) * | 2019-03-13 | 2020-09-17 | 南开大学 | 基于α螺旋把手提高蛋白核酸生物耦合效率的方法 |
| US11732044B2 (en) | 2017-12-27 | 2023-08-22 | Innovent Biologics (Suzhou) Co., Ltd. | Anti-LAG-3 antibody and use thereof |
| CN117083079A (zh) * | 2020-06-02 | 2023-11-17 | 儿童医学中心公司 | 纳米抗体(vhh)缀合物及其用途 |
| CN117255810A (zh) * | 2021-03-05 | 2023-12-19 | 杨百翰大学 | 用于使用分子内到分子间构象转换控制蛋白质二聚化的方法 |
Families Citing this family (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2417156E (pt) | 2009-04-07 | 2015-04-29 | Roche Glycart Ag | Anticorpos trivalentes, biespecíficos |
| US9676845B2 (en) | 2009-06-16 | 2017-06-13 | Hoffmann-La Roche, Inc. | Bispecific antigen binding proteins |
| CN102712696A (zh) | 2009-09-16 | 2012-10-03 | 弗·哈夫曼-拉罗切有限公司 | 包含卷曲螺旋和/或系链的蛋白质复合体及其用途 |
| TW201138821A (en) | 2010-03-26 | 2011-11-16 | Roche Glycart Ag | Bispecific antibodies |
| CN103068846B9 (zh) | 2010-08-24 | 2016-09-28 | 弗·哈夫曼-拉罗切有限公司 | 包含二硫键稳定性Fv片段的双特异性抗体 |
| EP2655413B1 (en) | 2010-12-23 | 2019-01-16 | F.Hoffmann-La Roche Ag | Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery |
| WO2012116926A1 (en) | 2011-02-28 | 2012-09-07 | F. Hoffmann-La Roche Ag | Antigen binding proteins |
| JP5768147B2 (ja) | 2011-02-28 | 2015-08-26 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 一価抗原結合タンパク質 |
| EP2726494B1 (en) | 2011-06-28 | 2017-01-04 | Whitehead Institute For Biomedical Research | Using sortases to install click chemistry handles for protein ligation |
| WO2013065009A1 (en) * | 2011-11-01 | 2013-05-10 | National Institute Of Immunology | A sortase-click reaction suite for synthesis of multivalent dendrimeric protein assembly |
| MX2014009565A (es) | 2012-02-10 | 2014-11-10 | Genentech Inc | Anticuerpos monocatenarios y otros heteromultimeros. |
| US9717685B2 (en) | 2012-03-26 | 2017-08-01 | President And Fellows Of Harvard College | Lipid-coated nucleic acid nanostructures of defined shape |
| CA2870485A1 (en) | 2012-04-13 | 2013-10-17 | Whitehead Institute For Biomedical Research | Sortase-modified vhh domains and uses thereof |
| US11339208B1 (en) | 2012-05-31 | 2022-05-24 | United States Of America As Represented By The Secretary Of The Air Force | Camelidae single-domain antibodies against Yersinia pestis and methods of use |
| US9267127B2 (en) | 2012-06-21 | 2016-02-23 | President And Fellows Of Harvard College | Evolution of bond-forming enzymes |
| KR20150030744A (ko) | 2012-06-27 | 2015-03-20 | 에프. 호프만-라 로슈 아게 | 표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Fc-영역 접합체의 제조 방법 및 그의 용도 |
| ES2597228T3 (es) * | 2012-06-27 | 2017-01-17 | F. Hoffmann-La Roche Ag | Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas |
| KR20150052085A (ko) | 2012-09-14 | 2015-05-13 | 에프. 호프만-라 로슈 아게 | 2개 이상의 상이한 단위를 포함하는 분자의 제조 및 선별 방법, 및 이의 용도 |
| WO2014145441A1 (en) | 2013-03-15 | 2014-09-18 | The Trustees Of The University Of Pennsylvania | Sortase-mediated protein purification and ligation |
| WO2014145654A1 (en) | 2013-03-15 | 2014-09-18 | The Trustees Of The University Of Pennsylvania | Method for the site-specific covalent cross-linking of antibodies to surfaces |
| DK3611180T3 (da) * | 2013-03-15 | 2022-02-28 | Biomolecular Holdings Llc | Hybrid immunoglobulin indeholdende ikke-peptidyl-binding |
| AU2014258109B2 (en) * | 2013-04-25 | 2016-09-29 | Abtlas Co., Ltd. | Method for refining protein including self-cutting cassette and use thereof |
| GB2529356B (en) * | 2013-04-28 | 2020-12-23 | Genequantum Healthcare Co Ltd | Novel linkers, coupling intermediates, conjugates, preparation method and application thereof |
| DK2991683T3 (da) | 2013-05-02 | 2019-11-04 | Glykos Finland Oy | Konjugater af et glykoprotein eller en glykan med en toksisk ladning |
| EP3693398A1 (en) * | 2013-05-10 | 2020-08-12 | Whitehead Institute for Biomedical Research | In vitro production of red blood cells with sortaggable proteins |
| US10260038B2 (en) | 2013-05-10 | 2019-04-16 | Whitehead Institute For Biomedical Research | Protein modification of living cells using sortase |
| JP2016523978A (ja) * | 2013-07-10 | 2016-08-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 核酸−タンパク質複合体に関する組成物及び方法 |
| WO2015042393A2 (en) * | 2013-09-20 | 2015-03-26 | President And Fellows Of Harvard College | Evolved sortases and uses thereof |
| BR112016006929A2 (pt) | 2013-10-11 | 2017-09-19 | Hoffmann La Roche | Anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, métodos de preparação de anticorpo, de tratamento de pacientes e de geração de um anticorpo, composição farmacêutica e uso do anticorpo |
| US10556024B2 (en) | 2013-11-13 | 2020-02-11 | Whitehead Institute For Biomedical Research | 18F labeling of proteins using sortases |
| CN104844711B (zh) * | 2014-02-18 | 2018-07-06 | 南通表源生物技术有限公司 | 一种多聚体荧光蛋白复合物及其应用 |
| EP4169944A1 (en) * | 2014-03-14 | 2023-04-26 | Biomolecular Holdings LLC | Process for preparing hybrid immunoglobulin containing non-peptidyl linkage |
| KR102460736B1 (ko) * | 2014-05-10 | 2022-10-31 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 화학적으로-로킹된 이중특이적 항체 |
| US10053683B2 (en) | 2014-10-03 | 2018-08-21 | Whitehead Institute For Biomedical Research | Intercellular labeling of ligand-receptor interactions |
| CA2964837C (en) | 2014-10-29 | 2023-10-17 | Ludwig-Maximilians-Universitaet Muenchen | Means and methods for site-specific functionalization of polypeptides |
| WO2016087416A1 (en) | 2014-12-03 | 2016-06-09 | F. Hoffmann-La Roche Ag | Multispecific antibodies |
| MX381723B (es) | 2014-12-17 | 2025-03-13 | Hoffmann La Roche | Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa. |
| JP6800154B2 (ja) | 2014-12-17 | 2020-12-16 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 結合形成酵素の活性アッセイ |
| BR112017010888A2 (pt) * | 2014-12-17 | 2018-02-27 | Hoffmann La Roche | método para produzir um produto de conjugação enzimática de três polipeptídeos |
| KR101637010B1 (ko) * | 2015-04-24 | 2016-07-07 | 광주과학기술원 | 위치 특이적으로 알부민이 연결된 요산 산화효소 및 단백질에 위치 특이적으로 알부민을 연결하는 방법 |
| TWI687228B (zh) * | 2015-05-11 | 2020-03-11 | 美商索倫多醫療公司 | 化學鎖固之雙特異性抗體 |
| US11123440B2 (en) | 2015-05-12 | 2021-09-21 | The Trustees Of The University Of Pennsylvania | Compositions and methods for making antibody conjugates |
| WO2016191200A1 (en) | 2015-05-22 | 2016-12-01 | Clemson University | Conotoxin peptides for use in biofouling deterrence |
| JP2017043547A (ja) * | 2015-08-24 | 2017-03-02 | 国立研究開発法人理化学研究所 | ポリペプチドを結合した成長因子及びその利用 |
| EP3353310B1 (en) | 2015-09-25 | 2020-04-29 | H. Hoffnabb-La Roche Ag | Process for producing thioesters employing a sortase a |
| CN108138158B (zh) | 2015-09-25 | 2021-11-09 | 豪夫迈·罗氏有限公司 | 可溶性分选酶a |
| US12048753B2 (en) | 2015-10-01 | 2024-07-30 | Whitehead Institute For Biomedical Research | Labeling of antibodies |
| EP3377112A4 (en) | 2015-11-18 | 2019-06-12 | Sorrento Therapeutics, Inc. | CHEMICALLY BLOCKED BISPECIFIC ANTIBODIES |
| DK3417058T3 (da) | 2016-02-16 | 2021-11-15 | Res Found Dev | Sortase-modificerede molekyler og anvendelser deraf |
| ES2911439T3 (es) | 2016-03-24 | 2022-05-19 | Genia Tech Inc | Procedimientos y composiciones de bioconjugación específica de sitio útiles para sistemas de nanoporos |
| CA3021526A1 (en) | 2016-04-28 | 2017-11-02 | Forschungsverbund Berlin E.V. | Unusual substrates of tubulin tyrosine ligase |
| AU2017295704B2 (en) | 2016-07-13 | 2023-07-13 | President And Fellows Of Harvard College | Antigen-presenting cell-mimetic scaffolds and methods for making and using the same |
| EP4372002A3 (en) | 2016-09-14 | 2024-08-14 | The Trustees Of The University Of Pennsylvania | Proximity-based sortase-mediated protein purification and ligation |
| US11298407B2 (en) * | 2016-09-21 | 2022-04-12 | The Governing Council Of The University Of Toronto | Hemoglobin based oxygen carrier and method of preparation |
| US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
| RS67792B1 (sr) | 2016-12-01 | 2026-03-31 | Regeneron Pharma | Radio-obeležena anti-pd-l1 antitela za imuno-pet snimanje |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| IL267709B2 (en) | 2016-12-30 | 2025-04-01 | Vaxcyte Inc | Polypeptide-antigen conjugates with unnatural amino acids |
| WO2018141959A1 (en) | 2017-02-06 | 2018-08-09 | Innate Pharma | Immunomodulatory antibody drug conjugates binding to a human mica polypeptide |
| WO2018165613A1 (en) | 2017-03-10 | 2018-09-13 | Prellis Biologics, Inc. | Methods and systems for printing biological material |
| BR112019018915A2 (pt) | 2017-03-15 | 2020-04-14 | Pandion Therapeutics Inc | imunotolerância direcionada |
| US11000604B2 (en) | 2017-05-17 | 2021-05-11 | Research Foundation Of The City University Of New York | Reagent for site-selective bioconjugation of proteins or antibodies |
| AU2018273914A1 (en) | 2017-05-24 | 2019-11-14 | Pandion Operations, Inc. | Targeted immunotolerance |
| JP2020524483A (ja) | 2017-05-25 | 2020-08-20 | プレリス バイオロジクス,インク. | 三次元印刷された器官、デバイス、およびマトリックス |
| DE102017115522B4 (de) * | 2017-07-11 | 2019-11-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Herstellung von Block-Polymeren mittels Verknüpfung von Blöcken durch eine Transpeptidase und Block-Polymere erhalten durch Transpeptidase-Verknüpfung |
| USRE50550E1 (en) | 2017-12-06 | 2025-08-26 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
| US10946068B2 (en) | 2017-12-06 | 2021-03-16 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
| US10174091B1 (en) | 2017-12-06 | 2019-01-08 | Pandion Therapeutics, Inc. | IL-2 muteins |
| JP2021506842A (ja) * | 2017-12-18 | 2021-02-22 | ヤンセン バイオテツク,インコーポレーテツド | ポリペプチドの放射性標識 |
| US11970537B2 (en) * | 2017-12-26 | 2024-04-30 | Nanjing GenScript Biotech Co., Ltd. | Fusion protein dimer using antibody Fc region as backbone and use thereof |
| CN111971060B (zh) * | 2017-12-29 | 2023-06-13 | 江南大学 | 募集抗体并靶向肿瘤细胞的双功能分子 |
| WO2019143631A1 (en) * | 2018-01-16 | 2019-07-25 | Phoenix Biomolecular Engineering Foundation | Universal viral vaccines |
| US11866482B2 (en) | 2018-02-07 | 2024-01-09 | Duke University | System and method for homogenous GPCR phosphorylation and identification of beta-2 adrenergic receptor positive allosteric modulators |
| GB201900621D0 (en) * | 2019-01-16 | 2019-03-06 | Ipsen Biopharm Ltd | Labelled polypeptides |
| AU2020234394B2 (en) * | 2019-03-08 | 2024-02-15 | AbTis Co., Ltd. | Site-specific antibody conjugation and antibody-drug conjugate as specific example thereof |
| WO2020210468A1 (en) | 2019-04-10 | 2020-10-15 | President And Fellows Of Harvard College | Nucleic acid nanostructures crosslinked with oligolysine |
| AU2020279240A1 (en) | 2019-05-20 | 2021-12-23 | Pandion Operations, Inc. | MAdCAM targeted immunotolerance |
| WO2020247724A1 (en) | 2019-06-07 | 2020-12-10 | Dana-Farber Cancer Institute, Inc. | Dna nanostructure-based vaccines |
| US20220259617A1 (en) | 2019-06-13 | 2022-08-18 | The General Hospital Corporation | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells |
| WO2021141924A1 (en) | 2020-01-07 | 2021-07-15 | Encodia, Inc. | Methods for stable complex formation and related kits |
| US11981715B2 (en) | 2020-02-21 | 2024-05-14 | Pandion Operations, Inc. | Tissue targeted immunotolerance with a CD39 effector |
| EP4157883A4 (en) * | 2020-06-02 | 2024-12-04 | Children's Medical Center Corporation | NANOBODY CONJUGATES (VHH) AND THEIR USES |
| WO2021246557A1 (ko) * | 2020-06-05 | 2021-12-09 | 주식회사 프로앱텍 | 특정한 갯수의 알부민이 연결된 요산산화효소-알부민 복합체 및 이의 제조 방법 |
| BR112023001272A2 (pt) | 2020-07-24 | 2023-04-04 | Massachusetts Gen Hospital | Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células |
| CN116685725A (zh) | 2020-08-19 | 2023-09-01 | Encodia 公司 | 顺序编码方法和相关试剂盒 |
| JP7844499B2 (ja) | 2021-03-08 | 2026-04-13 | ジーンクアンタム ヘルスケア (スーチョウ) シーオー., エルティーディー. | 抗体-免疫アゴニストコンジュゲート及びその使用 |
| EP4448722A4 (en) * | 2021-12-14 | 2025-12-03 | Prellis Biologics Inc | Three-dimensional synthetic lymphoid organs and organoids for antibody design and testing |
| AU2023226512A1 (en) | 2022-02-23 | 2024-08-29 | Bright Peak Therapeutics Ag | Immune antigen specific il-18 immunocytokines and uses thereof |
| EP4665378A2 (en) * | 2023-02-14 | 2025-12-24 | Georgia State University Research Foundation, Inc. | Anti-angiogenic agent and methods of using such agent |
| US20250186597A1 (en) | 2023-08-23 | 2025-06-12 | Bright Peak Therapeutics Ag | Targeted immune activation with il-18 immunocytokines |
| WO2025041101A1 (en) | 2023-08-23 | 2025-02-27 | Bright Peak Therapeutics Ag | Activatable il-18 immunocytokines and uses thereof |
| CN121969385A (zh) | 2023-09-11 | 2026-05-01 | 丹娜-法伯癌症研究院 | 含有il-2变体以增强car t细胞的功能性的car-衔接子 |
| WO2025238253A1 (en) | 2024-05-16 | 2025-11-20 | Synaffix B.V. | Antibody-oligonucleotide conjugates |
| WO2026008881A1 (en) | 2024-07-05 | 2026-01-08 | Synaffix B.V. | Extracellular vesicles comprising biomolecule-conjugates |
| WO2026069134A1 (en) | 2024-09-26 | 2026-04-02 | Bright Peak Therapeutics Ag | Human therapy with il-18 immunocytokines |
| WO2026083296A1 (en) | 2024-10-16 | 2026-04-23 | Bright Peak Therapeutics Ag | Trispecific compositions comprising il-18, vegf binding domains, and pd-1 binding domains |
| WO2026083295A1 (en) | 2024-10-16 | 2026-04-23 | Bright Peak Therapeutics Ag | Trispecific compositions comprising il-2, vegf binding domains, and pd-1 binding domains |
| WO2026143022A1 (en) | 2024-12-23 | 2026-07-02 | Point Loma Nazarene University | Antibody directed enzyme pro-drug therapy (adept) for cancer treatment using an antibody or fragment that binds to a cd206 receptor and 3-cyclopentyl-alpha-phenylalanine-methotrexate |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008148143A1 (en) * | 2007-06-06 | 2008-12-11 | University Of Wollongong | Diagnostics in a monoplex/multiplex format |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US5670132A (en) | 1994-09-20 | 1997-09-23 | Immunomedics, Inc. | Modified radioantibody fragments for reduced renal uptake |
| WO1998033809A1 (en) | 1997-01-31 | 1998-08-06 | The General Hospital Corporation | Compositions and methods for imaging gene expression |
| ATE375363T1 (de) | 1997-07-14 | 2007-10-15 | Bolder Biotechnology Inc | Derivate des wachstumshormons und verwandte proteine |
| US7101692B2 (en) | 1999-04-15 | 2006-09-05 | The Regents Of The University Of California | Identification of sortase gene |
| CA2365523A1 (en) | 1999-04-15 | 2000-10-26 | The Regents Of The University Of California | Identification of sortase gene |
| WO2002004030A2 (en) | 2000-07-06 | 2002-01-17 | Bristol-Myers Squibb Pharma Company | Stable radiopharmaceutical compositions |
| US7279304B2 (en) | 2000-12-18 | 2007-10-09 | President And Fellows Of Harvard College | Methods for preparation of macrocyclic molecules and macrocyclic molecules prepared thereby |
| CA2841097A1 (en) | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Albumin and g-csf fusion proteins |
| WO2004022593A2 (en) | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| ES2367430T3 (es) | 2002-12-23 | 2011-11-03 | Wyeth Llc | Anticuerpos contra pd-1 y sus usos. |
| US6960473B2 (en) | 2003-02-27 | 2005-11-01 | Istituto Superiore Di Sanita | In vitro mass production of human erythroid cells from the blood of normal donors and thalassemic patients |
| DE10335584B4 (de) | 2003-07-31 | 2006-06-29 | Philipps-Universität Marburg | Verfahren zur Herstellung zyklischer Moleküle |
| WO2005051976A2 (en) | 2003-11-20 | 2005-06-09 | Ansata Therapeutics, Inc. | Protein and peptide ligation processes and one-step purification processes |
| WO2005113592A2 (en) | 2004-05-19 | 2005-12-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
| CA2566561C (en) | 2004-06-04 | 2013-01-08 | Universite Pierre Et Marie Curie - Paris Vi | A method for producing red blood cells |
| US7524831B2 (en) | 2005-03-02 | 2009-04-28 | Schering Corporation | Treatments for Flaviviridae virus infection |
| PT2170959E (pt) | 2007-06-18 | 2014-01-07 | Merck Sharp & Dohme | Anticorpos para o receptor humano de morte programada pd-1 |
| JP2009189325A (ja) * | 2008-02-15 | 2009-08-27 | Kobe Univ | 第1級アミンを有する化合物をタンパク質の特定の部位に結合させる方法 |
| US8211656B2 (en) | 2008-08-13 | 2012-07-03 | The Invention Science Fund I, Llc | Biological targeting compositions and methods of using the same |
| WO2010098788A2 (en) | 2008-08-25 | 2010-09-02 | Amplimmune, Inc. | Pd-i antagonists and methods for treating infectious disease |
| EA201500417A1 (ru) | 2008-08-25 | 2015-11-30 | Эмплиммьюн, Инк. | Композиции антагонистов pd-1 и способы применения |
| WO2010033913A1 (en) | 2008-09-22 | 2010-03-25 | Icb International, Inc. | Antibodies, analogs and uses thereof |
| WO2010078376A2 (en) | 2008-12-30 | 2010-07-08 | Ventana Medical Systems, Inc. | Fc-specific polymer-conjugated antibodies and their diagnostic use |
| US8940501B2 (en) | 2009-01-30 | 2015-01-27 | Whitehead Institute For Biomedical Research | Methods for ligation and uses thereof |
| WO2010089411A2 (en) | 2009-02-09 | 2010-08-12 | Universite De La Mediterranee | Pd-1 antibodies and pd-l1 antibodies and uses thereof |
| AR080154A1 (es) | 2010-02-10 | 2012-03-14 | Immunogen Inc | Anticuerpos cd20 y su utilizacion |
| PL2539441T3 (pl) | 2010-02-22 | 2017-06-30 | Université Pierre Et Marie Curie (Paris 6) | Podłoże do hodowli komórkowej do wzrostu i różnicowania komórek linii hematopoetycznych |
| CN102892786B (zh) | 2010-03-11 | 2016-03-16 | Ucb医药有限公司 | Pd-1抗体 |
| US20130122043A1 (en) | 2010-04-20 | 2013-05-16 | Whitehead Institute For Biomedical Research | Modified polypeptides and proteins and uses thereof |
| WO2012142659A1 (en) | 2011-04-19 | 2012-10-26 | Baker Idi Heart And Diabetes Institute Holdings Limited | Site-selective modification of proteins |
| EP2726494B1 (en) | 2011-06-28 | 2017-01-04 | Whitehead Institute For Biomedical Research | Using sortases to install click chemistry handles for protein ligation |
| WO2013132317A1 (en) | 2012-03-07 | 2013-09-12 | Aurigene Discovery Technologies Limited | Peptidomimetic compounds as immunomodulators |
| CA2870485A1 (en) | 2012-04-13 | 2013-10-17 | Whitehead Institute For Biomedical Research | Sortase-modified vhh domains and uses thereof |
| US20140030697A1 (en) | 2012-06-14 | 2014-01-30 | Massachusetts Institute Of Technology | Sortase-mediated modification of viral surface proteins |
| US9267127B2 (en) | 2012-06-21 | 2016-02-23 | President And Fellows Of Harvard College | Evolution of bond-forming enzymes |
| EP3693398A1 (en) | 2013-05-10 | 2020-08-12 | Whitehead Institute for Biomedical Research | In vitro production of red blood cells with sortaggable proteins |
| US10260038B2 (en) | 2013-05-10 | 2019-04-16 | Whitehead Institute For Biomedical Research | Protein modification of living cells using sortase |
| US9878045B2 (en) | 2013-10-15 | 2018-01-30 | Regents Of The University Of Minnesota | Triorthogonal reagents for dual protein conjugation |
| US10556024B2 (en) | 2013-11-13 | 2020-02-11 | Whitehead Institute For Biomedical Research | 18F labeling of proteins using sortases |
| US10053683B2 (en) | 2014-10-03 | 2018-08-21 | Whitehead Institute For Biomedical Research | Intercellular labeling of ligand-receptor interactions |
-
2012
- 2012-06-28 EP EP12804570.5A patent/EP2726494B1/en active Active
- 2012-06-28 CA CA2840409A patent/CA2840409A1/en not_active Abandoned
- 2012-06-28 JP JP2014519003A patent/JP2014525904A/ja active Pending
- 2012-06-28 US US14/127,736 patent/US10081684B2/en active Active
- 2012-06-28 AU AU2012275390A patent/AU2012275390A1/en not_active Abandoned
- 2012-06-28 WO PCT/US2012/044584 patent/WO2013003555A1/en not_active Ceased
- 2012-06-28 CN CN201280042272.7A patent/CN103764665A/zh active Pending
-
2018
- 2018-09-24 US US16/140,384 patent/US11028185B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008148143A1 (en) * | 2007-06-06 | 2008-12-11 | University Of Wollongong | Diagnostics in a monoplex/multiplex format |
Non-Patent Citations (5)
| Title |
|---|
| JOHN M.ANTOS等: "Site-specific N- and C- terminal labeling of a single polypeptide using sortases of different specificity", 《 J.AM.CHEM.SOC.》 * |
| JUNPENG XIAO 等: "Synthesis of N-terminally linked protein dimmers and trimers by a combinded native chemical ligation-CuAAC click chemistry strategy", 《ORGANIC LETTERS》 * |
| LEVARY D.A.等: "Protein-Protein Fusion Catalyzed by Sortase A", 《PLOS ONE》 * |
| SLETTEN EM等: "Bioorthogonal chemistry: fishing for selectivity in a sea of functionally", 《ANGEW CHEM INT ED ENGL. 》 * |
| WITTE M.D.等: "Production of unnaturally linked chimeric proteins using a combination of sortase-catalyzed transpeptidation and click chemistry", 《NATURE PROTOCOLS》 * |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104130308A (zh) * | 2014-07-29 | 2014-11-05 | 吉林大学 | 一种蛋白质定点peg修饰的方法及所得peg修饰的蛋白质 |
| CN108026560A (zh) * | 2015-09-25 | 2018-05-11 | 豪夫迈·罗氏有限公司 | 在低共熔溶剂中使用分选酶的转酰胺反应 |
| CN108271375A (zh) * | 2015-09-25 | 2018-07-10 | 豪夫迈·罗氏有限公司 | 包含分选酶缀合环的重组免疫球蛋白重链及其缀合物 |
| CN109072212A (zh) * | 2016-03-30 | 2018-12-21 | 豪夫迈·罗氏有限公司 | 改善的分选酶 |
| CN109072212B (zh) * | 2016-03-30 | 2022-10-04 | 豪夫迈·罗氏有限公司 | 改善的分选酶 |
| US11732044B2 (en) | 2017-12-27 | 2023-08-22 | Innovent Biologics (Suzhou) Co., Ltd. | Anti-LAG-3 antibody and use thereof |
| WO2020151762A1 (zh) * | 2019-01-25 | 2020-07-30 | 信达生物制药(苏州)有限公司 | 新型双特异性抗体分子以及同时结合pd-l1和lag-3的双特异性抗体 |
| WO2020181756A1 (zh) * | 2019-03-13 | 2020-09-17 | 南开大学 | 基于α螺旋把手提高蛋白核酸生物耦合效率的方法 |
| US11505800B2 (en) | 2019-03-13 | 2022-11-22 | Nankai University | Method for improving bio-coupling efficiency between protein and nucleic acid based on alpha-helix handle |
| CN117083079A (zh) * | 2020-06-02 | 2023-11-17 | 儿童医学中心公司 | 纳米抗体(vhh)缀合物及其用途 |
| CN117255810A (zh) * | 2021-03-05 | 2023-12-19 | 杨百翰大学 | 用于使用分子内到分子间构象转换控制蛋白质二聚化的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2726494A4 (en) | 2014-12-24 |
| US20190112394A1 (en) | 2019-04-18 |
| EP2726494B1 (en) | 2017-01-04 |
| US10081684B2 (en) | 2018-09-25 |
| JP2014525904A (ja) | 2014-10-02 |
| CA2840409A1 (en) | 2013-01-03 |
| EP2726494A1 (en) | 2014-05-07 |
| AU2012275390A1 (en) | 2014-01-16 |
| US20140249296A1 (en) | 2014-09-04 |
| WO2013003555A1 (en) | 2013-01-03 |
| US11028185B2 (en) | 2021-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11028185B2 (en) | Using sortases to install click chemistry handles for protein ligation | |
| JP2014525904A5 (cg-RX-API-DMAC7.html) | ||
| US9751945B2 (en) | Sortase-modified VHH domains and uses thereof | |
| US11753669B2 (en) | Lysine conjugated immunoglobulins | |
| US10647765B2 (en) | Amino acid sequence presenting fusion polypeptide and its use | |
| CN104520327B (zh) | 单臂单价抗体构建体及其用途 | |
| EP3353201B1 (en) | Recombinant immunoglobulin heavy chains comprising a sortase conjugation loop and conjugates thereof | |
| CN108602878A (zh) | C端赖氨酸缀合免疫球蛋白 | |
| JP2016511279A (ja) | 免疫リガンド/ペイロード複合体の生産方法 | |
| JP2022511718A (ja) | 抗Taq DNAポリメラーゼ抗体及びその用途 | |
| US20210317233A1 (en) | Super Versatile Method for Imparting New Binding Specificity to Antibody | |
| AU2019266042B2 (en) | Artificial protein containing an antibody antigen-binding region, fused with bioactive peptides | |
| US10570197B2 (en) | Fd chain gene or L chain gene capable of increasing secretion amount of fab-type antibody | |
| HK1197554B (en) | Using sortases to install click chemistry handles for protein ligation | |
| HK1197554A (en) | Using sortases to install click chemistry handles for protein ligation | |
| JP2021141861A (ja) | 抗原に対する親和力が向上した抗体のスクリーニング方法および製造方法 | |
| NZ761205B2 (en) | Highly versatile method of presenting cyclic peptide on protein structure | |
| NZ761205A (en) | Highly versatile method of presenting cyclic peptide on protein structure | |
| NZ616871B2 (en) | Amino acid sequence presenting fusion polypeptide and its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140430 |